Wellgistics Health Inc (WGRX)

Wellgistics Health Inc. is a NASDAQ-listed common equity company in the healthcare sector. Through its business operations, the company is engaged in the wholesale and distribution of pharmaceutical products in the United States, serving pharmaceutical manufacturers and independent retail pharmacies. Its product mix includes branded and generic medicines, along with over-the-counter healthcare and consumer products. The company also provides third-party logistics services such as warehousing, inventory management, pick-and-pack operations, and shipping for small and mid-sized pharmaceutical manufacturers. In addition, Wellgistics Health operates DelivMeds, a pharmaceutical hub platform that supports prescription transfer workflows and backend clinical concierge services for independent pharmacies, and it maintains a retail community specialty business. Formerly known as Danam Health, Inc., the company adopted its current name in October 2024. Incorporated in 2022, Wellgistics Health is based in Tampa, Florida.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-WGRX
$3.65
6.6% Upside
Fair
Weak
0.0%
August 18, 2026
-0.1x
-0.5x
0.5x
6.801 M
35.48 M
80.9%
24.5%
-95.5
16.9%
Valuation • Fair Value

Wellgistics Health Inc (NASDAQ-WGRX) Fair Value by Valuation Model

Compare the primary fair value estimate for Wellgistics Health Inc (NASDAQ-WGRX) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$3.65

Estimated upside of 6.6% versus the current market price.

Fair Value Confidence

Very low

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$3.65

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Wellgistics Health Inc (NASDAQ-WGRX) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Wellgistics Health Inc (NASDAQ-WGRX)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

14.034 M

Current operating scale indicator.

Revenue Forecast

28.005 M

Forward revenue estimate.

EBITDA

-53.097 M

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review Wellgistics Health Inc (NASDAQ-WGRX) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Wellgistics Health Inc (NASDAQ-WGRX)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

1

Weak quality score that deserves closer review.

Beneish M-Score

-14.17

No elevated caution signal from this screen.

Altman Z-Score

-95.5

Lower score that deserves closer risk review.

FCF / Net Income

16.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Wellgistics Health Inc (NASDAQ-WGRX). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Wellgistics Health Inc (NASDAQ-WGRX)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 18, 2026

Days to Earnings

28

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Wellgistics Health Inc (NASDAQ-WGRX), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Wellgistics Health Inc (NASDAQ-WGRX) Stock Forecast & Technical Outlook

Review Wellgistics Health Inc (NASDAQ-WGRX) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Wellgistics Health Inc (NASDAQ-WGRX) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Wellgistics Health Inc (NASDAQ-WGRX) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Wellgistics Health Inc (NASDAQ-WGRX) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Wellgistics Health Inc (NASDAQ-WGRX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Wellgistics Health Inc (NASDAQ-WGRX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Wellgistics Health Inc (NASDAQ-WGRX)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Wellgistics Health Inc (NASDAQ-WGRX) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ Fast Investor Answers

Wellgistics Health Inc (NASDAQ-WGRX) Stock FAQ

Quick answers about Wellgistics Health Inc (NASDAQ-WGRX) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$3.65
Estimated upside 6.6%
Valuation Rating
Undervalued
Estimated upside of 6.6%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Weak
Current financial-health read

The current fair value estimate for Wellgistics Health Inc (NASDAQ-WGRX) is $3.65. This implies an estimated upside of 6.6% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 6.6% versus the current market price.

An analyst price target for Wellgistics Health Inc (NASDAQ-WGRX) is not currently available in the latest data file.

The current financial health read for Wellgistics Health Inc (NASDAQ-WGRX) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Wellgistics Health Inc (NASDAQ-WGRX) is August 18, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Wellgistics Health Inc (NASDAQ-WGRX) is -0.1x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Wellgistics Health Inc is 6.801 M.

The current enterprise value listed for Wellgistics Health Inc is 35.48 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Wellgistics Health Inc is NASDAQ-WGRX, and the stock is listed on NASDAQ.

Wellgistics Health Inc (NASDAQ-WGRX) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Wellgistics Health Inc is 80.9%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Wellgistics Health Inc is 24.5%. Free float helps investors understand how much of the share base is available for public trading.